000 01656nam  2200373zi 4500
0019.858206
003CaOODSP
00520221107155934
006m     o  d f      
007cr cn|||||||||
008180627t20192019onc     o    f000 0 eng d
020 |a9780660270289
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH13-9/15-2018E-PDF
24500|aGuidance document : |baddendum - quality (chemistry and manufacturing) guidance : questions and answers.
24630|aAddendum - quality (chemistry and manufacturing) guidance : |bquestions and answers
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2019.
264 4|c©2019
300 |a1 online resource (10 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : addenda - qualité (chimie et fabrication) : question et réponses.
500 |aCover title.
500 |a"Publication date: January 2019."
500 |aIssued also in HTML format.
69207|2gccst|aDrugs
69207|2gccst|aHealth policy
7101 |aCanada. |bHealth Canada.
77508|tLigne directrice : |w(CaOODSP)9.858208
85640|qPDF|s254 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H13-9-15-2018-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/chemical-entity-products-quality/guidance-document-addendum-quality-chemistry-manufacturing-guidance-questions-answers.html